ボツリヌストキシンの世界市場2021-2028

◆英語タイトル:GLOBAL BOTULINUM TOXIN MARKET FORECAST 2021-2028
◆商品コード:INK21JU007
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年5月3日
◆ページ数:187
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートはボツリヌストキシンの世界市場について調査・分析し、調査範囲/手法、エグゼクティブサマリー、市場動向、主要分析、種類別(A型、B型)分析、用途別(化粧品、非化粧品)分析、エンドユーザー別(病院、クリニック、その他)分析、地域別分析、競争状況などを掲載したものです。
・調査範囲/手法
・エグゼクティブサマリー
・市場動向
・主要分析
・ボツリヌストキシンの世界市場規模:種類別(A型、B型)
・ボツリヌストキシンの世界市場規模:用途別(化粧品、非化粧品)
・ボツリヌストキシンの世界市場規模:エンドユーザー別(病院、クリニック、その他)
・地域別分析
・競争状況
【レポートの概要】

KEY FINDINGS
The global botulinum toxin market is anticipated to project a CAGR of 5.14% during the forecast years of 2021 to 2028. The market growth is supplemented by leading factors, including the increased demand for aesthetic procedures, the rising patient preference for non-invasive or minimally invasive treatments, and the expansion of botulinum toxin into therapeutic applications.
MARKET INSIGHTS
Botulinum toxin entails a neurotoxic protein produced by the bacterium Clostridium botulinum as well as related species. The protein prevents the neurotransmitter acetylcholine’s release from axon endings located at the neuromuscular junction, thereby causing flaccid paralysis.
The surging demand for modern beauty standards has resulted in a tremendous growth platform for botulinum toxin products globally. The therapeutic applications for botulinum toxins have also led to increased developments across healthcare platforms. As per the National Clinical Trial (NCT) Registry, more than 80 ongoing and planned clinical trials associated with botulinum toxin are currently underway in diverse phases of development for various indications, as of October 2020. This factor is expected to positively impact the global market’s growth. Moreover, the high demand for botulinum toxin facilitates several product innovations, in addition to a subsequent rise in the number of product launches worldwide.
REGIONAL INSIGHTS
The global botulinum toxin market growth is assessed through the evaluation of North America, Europe, the Asia-Pacific, and the Rest of World. The Asia-Pacific is set to be the fastest-growing market for botulinum toxin, owing to drivers such as the surging geriatric population, the increasing awareness and interest in aesthetic procedures, and the growing purchasing power of the middle class on account of economic development. Furthermore, the market is highly diverse due to varied regulatory factors, leading to differences in product availability across countries.
COMPETITIVE INSIGHTS
Merz Pharma, Galderma SA, AbbVie Inc (Allergan), etc., are among the key companies operating in the global market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. RELATED MARKET ANALYSIS: AESTHETIC FILLER MARKET
3.2. KEY DRIVERS
3.2.1. INCREASING DEMAND FOR AESTHETIC PROCEDURES
3.2.2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
3.3. KEY RESTRAINTS
3.3.1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
3.3.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
3.3.3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY TYPE
5.1. TYPE A
5.2. TYPE B
6. MARKET BY APPLICATION
6.1. COSMETIC APPLICATIONS
6.1.1. GLABELLAR LINES
6.1.2. LATERAL CANTHAL LINES (CROW’S FEET)
6.1.3. FOREHEAD LINES
6.1.4. OTHER COSMETIC APPLICATIONS
6.2. NON-COSMETIC APPLICATIONS
6.2.1. DYSTONIA
6.2.2. CHRONIC MIGRAINE
6.2.3. OPHTHALMOLOGIC DISORDERS
6.2.4. OTHER NON-COSMETIC APPLICATIONS
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS AND OTHERS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. KEY GROWTH ENABLERS
8.1.2. KEY CHALLENGES
8.1.3. KEY PLAYERS
8.1.4. COUNTRY ANALYSIS
8.1.4.1. UNITED STATES
8.1.4.2. CANADA
8.2. EUROPE
8.2.1. KEY GROWTH ENABLERS
8.2.2. KEY CHALLENGES
8.2.3. KEY PLAYERS
8.2.4. COUNTRY ANALYSIS
8.2.4.1. UNITED KINGDOM
8.2.4.2. GERMANY
8.2.4.3. FRANCE
8.2.4.4. ITALY
8.2.4.5. RUSSIA
8.2.4.6. BELGIUM
8.2.4.7. POLAND
8.2.4.8. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. KEY GROWTH ENABLERS
8.3.2. KEY CHALLENGES
8.3.3. KEY PLAYERS
8.3.4. COUNTRY ANALYSIS
8.3.4.1. CHINA
8.3.4.2. JAPAN
8.3.4.3. INDIA
8.3.4.4. SOUTH KOREA
8.3.4.5. SINGAPORE
8.3.4.6. THAILAND
8.3.4.7. VIETNAM
8.3.4.8. AUSTRALIA & NEW ZEALAND
8.3.4.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
8.4.1. KEY GROWTH ENABLERS
8.4.2. KEY CHALLENGES
8.4.3. KEY PLAYERS
8.4.4. REGIONAL ANALYSIS
8.4.4.1. LATIN AMERICA
8.4.4.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. PRODUCT LAUNCHES & DEVELOPMENTS
9.2. COMPANY PROFILES
9.2.1. ABBVIE INC (ALLERGAN PLC)
9.2.2. EVOLUS INC
9.2.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
9.2.4. HUGEL INC
9.2.5. IPSEN PHARMA
9.2.6. MEDYTOX INC
9.2.7. MERZ PHARMA
9.2.8. REVANCE THERAPEUTICS INC
9.2.9. US WORLDMEDS LLC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - BOTULINUM TOXIN
TABLE 2: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL TYPE A MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GLOBAL TYPE A MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL TYPE B MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GLOBAL TYPE B MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL COSMETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GLOBAL COSMETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL GLABELLAR LINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: GLOBAL GLABELLAR LINES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: GLOBAL LATERAL CANTHAL LINES (CROW’S FEET) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: GLOBAL LATERAL CANTHAL LINES (CROW’S FEET) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: GLOBAL FOREHEAD LINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: GLOBAL FOREHEAD LINES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: GLOBAL OTHER COSMETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: GLOBAL OTHER COSMETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: GLOBAL NON-COSMETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 23: GLOBAL NON-COSMETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 24: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 25: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 26: GLOBAL DYSTONIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 27: GLOBAL DYSTONIA MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 28: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 29: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 30: GLOBAL OPHTHALMOLOGIC DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 31: GLOBAL OPHTHALMOLOGIC DISORDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 32: GLOBAL OTHER NON-COSMETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 33: GLOBAL OTHER NON-COSMETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 34: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 35: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 36: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 37: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 38: GLOBAL CLINICS AND OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 39: GLOBAL CLINICS AND OTHERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 40: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 41: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 42: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 43: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 44: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 45: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 46: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 47: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 48: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 49: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 50: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2020
FIGURE 6: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020
FIGURE 9: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
FIGURE 20: GLOBAL BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)
FIGURE 22: NORTH AMERICA BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 23: UNITED STATES BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 24: CANADA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 25: EUROPE BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 26: UNITED KINGDOM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 27: GERMANY BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 28: FRANCE BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 29: ITALY BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 30: RUSSIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: BELGIUM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: POLAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: REST OF EUROPE BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 35: CHINA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: JAPAN BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: INDIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: SOUTH KOREA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 39: INDONESIA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 40: THAILAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 41: VIETNAM BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 42: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 43: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION
FIGURE 44: REST OF WORLD BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 45: LATIN AMERICA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)
FIGURE 46: MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ボツリヌストキシンの世界市場2021-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆